What's in Axxonis Pharma AG's pipeline?

Axxonis Pharma AG has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Axxonis Pharma AG's portfolio?

Top competitors by shared drug class: Beth Israel Deaconess Medical Center, Britannia Pharmaceuticals Ltd., Desitin Arzneimittel GmbH, GlaxoSmithKline, Intec Pharma Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/axxonis-pharma-ag.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Axxonis Pharma AG — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Axxonis Pharma AG pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Continuous Subcutaneous Lisuride Infusion	Continuous Subcutaneous Lisuride Infusion	phase 3	Dopamine agonist	D1 and D2 dopamine receptors	Neurology

Therapeutic area mix

Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beth Israel Deaconess Medical Center · 1 shared drug class
Britannia Pharmaceuticals Ltd. · 1 shared drug class
Desitin Arzneimittel GmbH · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Intec Pharma Ltd. · 1 shared drug class
Leiden University Medical Center · 1 shared drug class
Ludwig-Maximilians - University of Munich · 1 shared drug class
Beijing Bozhiyin T&S Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Axxonis Pharma AG:

Cite this brief

Drug Landscape (2026). Axxonis Pharma AG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/axxonis-pharma-ag. Accessed 2026-06-10.